Elevance Health Overview
Elevance Health Target Price
Analysts' average 12-month price target for Elevance Health is $450.
Get informed when a big investor buys or sells
+ FollowShare Price
$396.09
Average Target Price
$448.18
13.2% upside
13.2% upside17 analysts in the last 4 months
High: $492 | Low: $393
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-17 | Leerink Partners | $395 |  0.3% downside |  |
| 2026-07-16 | Bernstein | $488 | 23.2% upside | |
| 2026-07-16 | Barclays | $457 | 15.4% upside | |
| 2026-07-16 | Wells FargoStephen Baxter | $473 | 19.4% upside | |
| 2026-07-16 | Guggenheim | $455 | 14.9% upside | |
| 2026-07-16 | Robert W. Baird | $393 | 0.8% downside | |
| 2026-07-16 | Goldman Sachs | $395 | 0.3% downside | |
| 2026-07-16 | RBC Capital | $424 | 7% upside | |
| 2026-07-16 | New Street | $482 | 21.7% upside | |
| 2026-07-14 | Truist Financial | $475 | 19.9% upside | |
| 2026-07-13 | Wells Fargo | $492 | 24.2% upside | |
| 2026-07-09 | RBC CapitalBen Hendrix | $439 | 10.8% upside | |
| 2026-07-07 | Raymond JamesSarah James | $450 | 13.6% upside | |
| 2026-07-02 | Bernstein | $482 | 21.7% upside | |
| 2026-06-08 | Mizuho Securities | $465 | 17.4% upside | |
| 2026-06-04 | Morgan Stanley | $404 | 2% upside | |
| 2026-06-01 | Truist FinancialDavid MacDonald | $450 | 13.6% upside | |
| 2026-05-26 | BarclaysAndrew Mok | $480 | 21.2% upside | |
| 2026-05-22 | UBS | $460 | 16.1% upside | |
| 2026-05-20 | Deutsche Bank | $498 | 25.7% upside | |
| 2026-05-20 | Mizuho Securities | $435 | 9.8% upside | |
| 2026-04-24 | Barclays | $408 | 3% upside | |
| 2026-04-24 | Guggenheim | $399 | 0.7% upside | |
| 2026-04-23 | Leerink Partners | $364 | 8.1% downside | |
| 2026-04-23 | Robert W. Baird | $331 | 16.4% downside | |
| 2026-04-20 | JefferiesDavid Windley | $391 | 1.3% downside | |
| 2026-03-10 | Mizuho SecuritiesAnn Hynes | $350 | 11.6% downside | |
| 2026-02-03 | RBC Capital | $358 | 9.6% downside | |
| 2026-02-02 | Truist Financial | $390 | 1.5% downside | |
| 2026-02-02 | Piper Sandler | $409 | 3.3% upside | |
| 2026-02-02 | Craig-Hallum | $409 | 3.3% upside | |
| 2026-02-01 | Bernstein | $409 | 3.3% upside | |
| 2026-01-30 | Wells Fargo | $391 | 1.3% downside | |
| 2026-01-30 | Barclays | $393 | 0.8% downside | |
| 2026-01-29 | UBS | $400 | 1% upside | |
| 2026-01-29 | Deutsche Bank | $332 | 16.2% downside | |
| 2026-01-29 | GuggenheimJason Cassorla | $396 | 0% upside | |
| 2026-01-22 | GuggenheimJason Cassorla | $414 | 4.5% upside | |
| 2026-01-09 | Mizuho SecuritiesAnn Hynes | $413 | 4.3% upside | |
| 2026-01-08 | Wolfe ResearchJustin Lake | $425 | 7.3% upside | |
| 2026-01-07 | Wells Fargo | $424 | 7% upside | |
| 2026-01-06 | Bernstein | $431 | 8.8% upside | |
| 2026-01-05 | BarclaysAndrew Mok | $404 | 2% upside | |
| 2025-12-19 | Deutsche BankGeorge Hill | $320 | 19.2% downside | |
| 2025-12-18 | Morgan Stanley | $352 | 11.1% downside | |
| 2025-11-03 | Mizuho Securities | $400 | 1% upside | |
| 2025-10-22 | Barclays | $385 | 2.8% downside | |
| 2025-10-21 | Bernstein | $420 | 6% upside | |
| 2025-10-14 | Goldman Sachs | $343 | 13.4% downside | |
| 2025-10-14 | Truist Financial | $400 | 1% upside | |